Comparative analysis of two types of 5-hydroxytryptamine receptor mediating vasorelaxation: differential classification using tryptamines.
Two receptors mediating relaxant responses to 5-hydroxytryptamine (5-HT) were studied comparatively in rings of rabbit jugular vein contracted with U-46619 (10 nmol/l). At low concentrations of 5-HT (0.001-0.1 mumol/l) vascular relaxation was mediated indirectly by the endothelial 5-HT receptor previously described by Leff et al. (1987). In preparations denuded of endothelium, higher concentrations of the amine (0.03-30 mumol/l) caused relaxation responses directly, presumably via a receptor located on the smooth muscle cells. Similarity between the receptors was evident in that both were susceptible to antagonism by methysergide, but resistant to blockade by ketanserin and MDL 72222. In these respects, the receptors qualified for a '5-HT1-like' classification. Consistent with this, 5-carboxamidotryptamine demonstrated a higher agonist potency than 5-HT at the receptor mediating relaxation directly. However, in endothelium-intact jugular vein rings this potency order was reversed, showing that the endothelial 5-HT receptor did not satisfy completely the criteria for a '5-HT1-like' designation. When the activities of a single set of tryptamines were compared in endothelium-intact and -denuded jugular vein rings, different affinity and relative efficacy estimates were obtained, confirming that two distinct 5-HT receptors mediate relaxation responses in this tissue. The most striking difference between these two receptor types was demonstrated by alpha-methyl-5-HT since it expressed a high affinity comparable to 5-HT at the endothelial receptor, but was inactive at the receptor in endothelium-denuded preparations at concentrations up to 30 mumol/l.(ABSTRACT TRUNCATED AT 250 WORDS)
Department of Pharmacology I, Wellcome Research Laboratories, Beckenham, Kent, UK.
G R
GR
Martin
P
P
Leff
D
D
Cambridge
V J
VJ
Barrett
D000818:Animals; D004730:Endothelium, Vascular / Q000502:physiology; D066298:In Vitro Techniques; D007650:Ketanserin / Q000494:pharmacology; D008297:Male; D010424:Pentobarbital / Q000494:pharmacology; D011817:Rabbits; D051381:Rats; D011919:Rats, Inbred Strains; D011985:Receptors, Serotonin / Q000187:drug effects / Q000502:physiology*; D013134:Spiperone / Q000494:pharmacology; D014363:Tryptamines / Q000494:pharmacology*; D014664:Vasodilation / Q000187:drug effects*
D011985:Receptors, Serotonin; D014363:Tryptamines; D013134:Spiperone; D007650:Ketanserin; D010424:Pentobarbital